I think this one looks clearer… the text is darker on this one!

CC for interest
@kristenyoung.bsky.social
@rheumcat.bsky.social
@lupusdnadoc.bsky.social
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusresearch.bsky.social

@rheumcat.bsky.social
@kristenyoung.bsky.social
@lupuschat.bsky.social
@lupusdnadoc.bsky.social
@lupusencyclopedia.bsky.social
@lupusresearch.bsky.social

🏷️ for Interest
@rheumnow.bsky.social
@jeffsparks.bsky.social
@pulmpeeps.bsky.social
@icuonepager.bsky.social
@drpujamehta1.bsky.social
@pulmtoilet.bsky.social
@pulmcrit.bsky.social
@thanhneville.medsky.social
@critconcepts.bsky.social
@gretchemaben.bsky.social
@laxswamy.bsky.social

Thank you! 😊

🏷️ for Interest
@jeffsparks.bsky.social
@pulmpeeps.bsky.social
@icuonepager.bsky.social
@nickmark.bsky.social
@drpujamehta1.bsky.social
@rheumcat.bsky.social
@didemsayginmd.bsky.social
@kristenyoung.bsky.social
@pulmtoilet.bsky.social
@pulmcrit.bsky.social

So often for FUO consults with ID and Heme/Onc 😂

Oh sounds interesting! Look forward to reading that.

@lupuschat.bsky.social @lupusdnadoc.bsky.social @ashira-md.bsky.social @alhkim.bsky.social @rheumcat.bsky.social @kristenyoung.bsky.social @creakyjoints.bsky.social @lupusresearch.bsky.social

Yes good Q whether earlier targeting in the B-cell pathway with inebilizumab will make a significant difference with broader B cell depletion!

Wonder if anyone else on #RheumSky has thoughts!

Love this #HealthLiteracy 🙌🏽